Preventive Oncology & Epidemiology is an online, open access, international journal publishing original research, reviews, commentaries and study protocols across all areas of cancer epidemiology and prevention.
Cancer epidemiology is defined as the study of the distribution and determinants of cancer(s), allowing researchers to ascertain the possible trends and causes of cancer development amongst different populations. Cancer prevention focuses on identifying possible candidates for preventing cancer and testing interventions to reduce the risk of developing cancer. This includes behavioral factors (for example, diet, exercise, obesity prevention, sun protection, and tobacco use), chemoprevention, the use of vaccines, and the uptake of cancer screening/early detection tests. Furthermore, cancer prevention includes intervention research (patient navigation, computer-aided reminders, clinic and provider-based programs for example), as well as the validation and use of early detection tests and biomarkers.
Promoting collaboration across all disciplines, from nutrition to cancer health policy, Preventive Oncology & Epidemiology is the home for researchers dedicated to advancing innovations within cancer epidemiology and prevention.
Topics covered include, but are not limited to:
Research focusing on early detection strategies, such as screening programmes, as well as the identification/validation of novel biomarkers that could lead to the creation of innovative early detection diagnostics;
The implementation of interventions and programmes at a community, state, or country level. The journal also wishes to highlight the barriers associated with implementing community health interventions and the unique challenges impacting underserved and minority populations and different settings;
The implications of state or country health policies on cancer epidemiology and prevention efforts;
Research focusing on geographical variations and trends in cancer distribution, within and between populations, at the state or country level; and
Community education and engagement strategies to raise awareness of lifestyle risk factors, prevention, and early detection strategies.
The journal accepts the following article types: Original Research, Reviews (systematic and meta-analyses), Brief Reports, Editorials, Letters to the Editor, Commentaries, and Study Protocols.
Preventive Oncology & Epidemiology operates a single-anonymzied peer review policy.
Journal metrics
Usage
527 annual downloads/views
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Editor-in-Chief: Professor Electra Paskett - Ohio State University, USA
Deputy Editor: Dr. Matthew Banegas - University of California San Diego, USA Editorial Board: Professor Humaid Al-Shamsi - Burjeel Medical Center, United Arab Emirates Professor Nirmala Bhoo-Pathy - University Malaya Medical Centre, Malaysia Professor Melissa Bondy - Stanford University, USA Professor Heather Brandt – St. Jude Children’s Research Hospital, USA Dr Tracy Crane - University of Miami, USA Dr Javiera Martinez Gutierrez – University of Melbourne, Australia Professor Klaus Puschel Illanes – Pontifical Catholic University of Chile, Chile Professor Regi Jose - Sree Gokulam Medical College, India Professor Janice Krieger - University of Florida, USA Dr Amy Leader - Thomas Jefferson University, USA Professor Jamie Studts - University of Colorado, USA Professor Sujha Subramanian – Implenomics, USA Professor Mary Beth Terry – Columbia University, USA Dr Katherine Tossas - Virginia Commonwealth University, Massey Comprehensive Cancer Center, USA Professor Amy Trentham-Dietz - University of Wisconsin, USA
Open access
Preventive Oncology & Epidemiology is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![Oncology Central: Breaking news, peer-reviewed articles, webinars, and much more...]({"type":"image" , "src" : "/sda/112452/journalad-promotion-oncology-central.png"})